Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons
Open Access
- 20 March 2010
- journal article
- Published by Public Library of Science (PLoS) in PLoS Currents
- Vol. 2, RRN1153
- https://doi.org/10.1371/currents.rrn1153
Abstract
The on-going debate about the health burden of the 2009 influenza pandemic and discussions about the usefulness of vaccine recommendations has been hampered by an absence of directly comparable measures of mortality impact. Here we set out to generate an “apples-to-apples” metric to compare pandemic and epidemic mortality. We estimated the mortality burden of the pandemic in the US using a methodology similar to that used to generate excess mortality burden for inter-pandemic influenza seasons. We also took into account the particularly young age distribution of deaths in the 2009 H1N1 pandemic, using the metric “Years of Life Lost” instead of numbers of deaths. Estimates are based on the timely pneumonia and influenza mortality surveillance data from 122 US cities, and the age distribution of laboratory-confirmed pandemic deaths, which has a mean of 37 years. We estimated that between 7,500 and 44,100 deaths are attributable to the A/H1N1 pandemic virus in the US during May-December 2009, and that between 334,000 and 1,973,000 years of life were lost. The range of years of life lost estimates includes in its lower part the impact of a typical influenza epidemic dominated by the more virulent A/H3N2 subtype, and the impact of the 1968 pandemic in its upper bound. We conclude that the 2009 A/H1N1 pandemic virus had a substantial health burden in the US over the first few months of circulation in terms of years of life lost, justifying the efforts to protect the population with vaccination programs. Analysis of historic records from three other pandemics over the last century suggests that the emerging pandemic virus will continue to circulate and cause excess mortality in unusually young populations for the next few years. Continuing surveillance for indicators of increased mortality is of key importance, as pandemics do not always cause the majority of associated deaths in the first season of circulation.Keywords
This publication has 21 references indexed in Scilit:
- The Spanish influenza pandemic in occidental Europe (1918–1920) and victim ageInfluenza and Other Respiratory Viruses, 2010
- Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009Emerging Infectious Diseases, 2009
- Severe Respiratory Disease Concurrent with the Circulation of H1N1 InfluenzaNew England Journal of Medicine, 2009
- The Signature Features of Influenza Pandemics — Implications for PolicyNew England Journal of Medicine, 2009
- Cross‐Protection between Successive Waves of the 1918–1919 Influenza Pandemic: Epidemiological Evidence from US Army Camps and from BritainThe Journal of Infectious Diseases, 2008
- Prioritization of Influenza Pandemic Vaccination to Minimize Years of Life LostThe Journal of Infectious Diseases, 2008
- Epidemiologic Characterization of the 1918 Influenza Pandemic Summer Wave in Copenhagen: Implications for Pandemic Control StrategiesThe Journal of Infectious Diseases, 2008
- Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysisThe Lancet, 2006
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLoS Medicine, 2006
- Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a Smoldering PandemicThe Journal of Infectious Diseases, 2005